Clinical Trial UCI-17-50 Click to view printable page


A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-399, an Antibody Drug Conjugate, in Subjects with Advanced Solid Tumors

Principal Investigator

Sai-Hong Ignatius Ou


Learn More

For information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email

If you would like more information regarding this specific trial, please leave your name, phone number, and email. We will contact you promptly.

Name: Email: Phone: